Drug Screening Market Size 2022 | Industry Share, Report and Global Forecast till 2027

The latest research study “Drug Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global drug screening market size reached a value of US$ 5.42 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.36 Billion by 2027, exhibiting a CAGR of 9.30% during 2022-2027.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/drug-screening-market/requestsample

Drug screening is the process of analyzing samples of blood, urine, hair, or saliva with immunoassays (IAs) or gas chromatography (GC) with mass spectrometry (MS) to identify the presence of a drug in the body. It is used in numerous settings, such as legal prosecution, risk management, rehabilitation, clinical care, and occupational health. It also helps evaluate patients receiving opioid therapy for adherence and abuse potential. In addition, it aids in the triage of patients with altered mental conditions in rehabilitation. As a result, drug screening finds extensive applications in different medical settings across the globe.

COVID-19Impact on Market: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Drug Screening Market Trends and Drivers:

The global drug screening market is primarily driven by the rising emphasis on creating a safe workplace, as drug abuse can adversely affect employee health, safety, productivity, and morale. Moreover, the increasing number of fatal road accidents has augmented the demand for drug screening to maintain road safety. Additionally, governments of numerous countries are implementing stringent policies to mandate drug screening for military, national security, personnel law enforcement, and public health, which has catalyzed market growth.

Furthermore, there has been widespread product usage in sports and athletic competitions to identify performance-enhancing drugs such as steroids and human growth hormone (HGH) in professional athletes. In line with this, the rising participation of individuals in professional sports is another major growth-inducing factor.

Besides this, the increasing number of opioid dependency and pain management clinics is contributing to the market growth. Other factors, including the growing incidences of substance abuse and illegal drug use by teenagers and the rising alcohol consumption, are also anticipated to create a favorable market outlook.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/drug-screening-market

Drug Screening Market Report Scope
Report CoverageDetails
Market size value in 2021US$ 5.42 Billion
Market forecast in 2027US$ 9.36 Billion
Growth RateCAGR of 9.30% from 2022 to 2027
Base year for estimation2021
Historical data2016-2021
Forecast period2022-2027

Global Drug Screening Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Drug Screening Companies:

Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG and Thermo Fisher Scientific Inc.

The report has segmented the market on the basis of region, product and service, sample type and end user.

Breakup by Product and Service:

  • Equipment
    • Immunoassay Analyzers
    • Chromatography Instruments
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
    • Assay Kits
    • Sample Collection Cups
    • Calibrators and Controls
    • Others
  • Laboratory Services

Breakup by Sample Type:

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Others

Breakup by End User:

  • Hospitals
  • Drug Testing Laboratories
  • Workplaces
  • Drug Treatment Centers
  • Pain Management Centers
  • Personal Users
  • Criminal Justice System and Law Enforcement Agencies

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

biz-strategy

Learn More →

Leave a Reply

Your email address will not be published.